Multi-DDA: drug–disease association prediction using a hybrid graph convolutional network with multi-modal drug representations
Bioinformatics Advances · 07.01.2026 · 6 (1)
DOI: 10.1093/bioadv/vbag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics Advances, online erschienen am 17.04.2026. Verfasst von Alireza Dehghan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Engineering, Faculty of Technology and Engineering, Salman Farsi University of Kazerun, Kazerun 7319673544, Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Motivation Predicting drug–disease associations (DDAs) is essential for efficient drug repurposing. Although graph convolutional networks (GCNs) on heterogeneous drug–disease graphs are state-of-the-art, they often underutilize the rich, multi-modal data available for drugs, such as targets, enzymes, pathways, and chemical substructures. Results To address this, we introduce Multi-DDA, a novel framework that systematically integrates these multi-modal drug features into a dedicated learning branch. These enriched drug descriptors are hierarchically combined with the outputs of each graph convolution layer, allowing subsequent layers to selectively refine the most informative node representations. This multi-modal fusion creates more comprehensive drug and disease embeddings. The representations are then processed by a graph attention layer to weigh the importance of different node connections before a final Multi-Layer Perceptron predicts the association matrix. Evaluated on a benchmark dataset of 269 drugs and 598 diseases, Multi-DDA outperforms seven existing methods across key metrics—Area Under the Precision-Recall Curve (AUPR), Area Under the Receiver Operating Characteristic Curve (AUC), and Recall. The significant gains in AUPR and Recall demonstrate its enhanced capability to identify potential DDAs, offering a powerful tool for advancing personalized medicine and drug discovery. Availability and implementation The source code for Multi-DDA is freely available at https://github.com/dehghan1401/Multi-DDA
Autor:innen und Institutionen
- Department of Computer Engineering, Faculty of Technology and Engineering, Salman Farsi University of Kazerun, Kazerun 7319673544, Iran.
- Mosaheb Institute for Mathematical Research, Kharazmi University, Tehran 1571914911, Iran.
ORCID-Profile: Karim Abbasi
Zitieren
APA
Dehghan, A., Abbasi, K., & Kazemi Najaf Abadi, M. R. (2026). Multi-DDA: drug–disease association prediction using a hybrid graph convolutional network with multi-modal drug representations. Bioinformatics Advances, 6(1). https://doi.org/10.1093/bioadv/vbag034
Vancouver
Dehghan A, Abbasi K, Kazemi Najaf Abadi MR. Multi-DDA: drug–disease association prediction using a hybrid graph convolutional network with multi-modal drug representations. Bioinformatics Advances. 2026;6(1). doi:10.1093/bioadv/vbag034
BibTeX
@article{Dehghan2026,
author = {Dehghan, Alireza and Abbasi, Karim and Kazemi Najaf Abadi, Mohammad Rasoul},
title = {Multi-DDA: drug–disease association prediction using a hybrid graph convolutional network with multi-modal drug representations},
journal = {Bioinformatics Advances},
year = {2026},
volume = {6},
number = {1},
doi = {10.1093/bioadv/vbag034}
}
EUVIMED